Govt approves FDC of Tamsulosin HCL + Deflazacort for asthma therapy

Govt approves FDC of Tamsulosin HCL + Deflazacort for asthma therapy

184
Govt of India

The Union health ministry has amended the notification dated July 23, 1983 and has finally approved the fixed dose combination (FDC) of tamsulosin HCI + deflazacort for asthma therapy.

Medicine Tablets
Picture: Unsolash

As per Union health ministry notification, “Union health ministry has approved to exclude the FDC of tamsulosin HCI 0.4 mg (as film coated modified release tablet) + deflazacort 30mg hard gelatin capsule from the prohibition made via notification dated October 9, 2009 through an amendment of the said notification number G.S.R. 578(E), dated July 23, 1983 and substituted item 14 and the entries relating thereto with the entry “Fixed dose combination of corticosteroid with any other drug for internal use except for preparations meant for meter dose inhalers and dry powder inhalers”.

To read or download the notification, click here

Notification dated July 23, 1983 prohibited the manufacture and sale of FDCs of steroids for internal use except combination of steroids with other drugs for the treatment of asthma.

The Central government had earlier also vide notification dated October 9, 2009 amended the said notification dated July 23, 1983 and substituted item 14 and the entries relating thereto with the entry “Fixed dose combination of corticosteroid with any other drug for internal use except for preparations meant for meter dose inhalers and dry powder inhalers.”


Also read:

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

PM interacts with leaders of Pharma industry

Sting operation: 2 held for Remdesivir black marketing

Pharma Ind appeals to DoP to keep new PLI scheme open…


Now therefore, in exercise of the powers conferred by Section 26A of the Drugs and Cosmetics (D&C) Act, 1940 (23 of 1940), the Central government, after consultation with the Drugs Technical Advisory Board, hereby makes the following amendments further to amend the notification number G.S.R. 578(E), dated the 23rd July, 1983, namely:—

Also read about banned drugs notifications, click here

In the notification, in the Table, for item 14 and the entries relating thereto, the following item and entries shall be substituted, namely:—”14. Fixed dose combination of corticosteroid with any other drug [excluding fixed dose combination of tamsulosin HCI 0.4mg (as film coated modified release tablet) + deflazacort 30mg in hard gelatin capsule] for internal use except for preparations meant for meter dose inhalers and dry powder inhalers.”

FDC of tamsulosin HCI 0.4 mg (as film coated modified release tablet) + deflazacort 30 mg hard gelatin capsule was also examined by Prof. Kokate Committee constituted by the Central government for examining the safety and efficacy of FDCs which were licensed prior to October 1, 2012 without prior approval of the Central Licensing Authority (CLA).

Therefore, Prof. Kokate Committee examined the said FDC in current scenario based on the available documents and scientific literature and considered this FDC as rational and accordingly, the FDC of tamsulosin HCI 0.4mg (as film coated modified release tablet) + deflazacort 30 mg hard gelatin capsule was approved.

FDC of tamsulosin HCI 0.4 mg (as film coated modified release tablet) + deflazacort 30 mg hard gelatin capsule was then referred to Drugs Technical Advisory Board (DTAB) and upon examination, the DTAB has recommended to exclude the FDC of tamsulosin HCI 0.4 mg (as film coated modified release tablet) + deflazacort 30 mg hard gelatin capsule from the prohibition made vide notification number G.S.R.738 (E), dated October 9, 2009.


Enter your email address:

Delivered by FeedBurner

Latest updates

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Subscribe here for daily updates
Loading